Study to Assess the Efficacy, Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latanoprost in Patients With Ocular Hypotension or Open Angle Glaucoma
Conditions: Ocular Hypertension; Primary Open Angle Glaucoma Interventions: Drug: Latanoprost ophthalmic solution; Drug: AKB-9778; Drug: Placebo Sponsor: Aerpio Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials